Delaying the Onset of Type 1 Diabetes with Teplizumab: A Narrative Review of Autoantibody Screening and Who Would Actually Be Treated. Journal of Clinical Diabetes and Obesity, [S. l.], v. 2, n. 1, p. 7–12, 2022. DOI: 10.5281/zenodo.22238844. Disponível em: https://pragmajournals.org/index.php/JCDO/article/view/316. Acesso em: 30 oct. 2026.